BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/bj-2014-0020
Sanjeev Sharma, M. Mathur, D. Prasad, Ajay K. Singh, R. Garsa, Rajesh Kumar, P. Beniwal, D. Agarwal, V. Malhotra
{"title":"Are we Treating or Curing Tuberculosis? Profile of Secondary Renal Amyloidosis in Patients Receiving Anti Tubercular Treatment","authors":"Sanjeev Sharma, M. Mathur, D. Prasad, Ajay K. Singh, R. Garsa, Rajesh Kumar, P. Beniwal, D. Agarwal, V. Malhotra","doi":"10.2478/bj-2014-0020","DOIUrl":"https://doi.org/10.2478/bj-2014-0020","url":null,"abstract":"Abstract Introduction. Secondary renal amyloidosis due to tuberculosis is a debilitating disease with considerable mortality and morbidity due to renal failure and other manifestations of both amyloidosis and renal failure. Most patients with amyloidosis have been adequately treated with DOTS (Directly observed treatment, Short Course strategy). The aimof our study was to analyze the epidemiological and demographic profile of patients undergoing renal biopsy and found to have renal amyloidosis secondary to tuberculosis. Methods. In this study, retrospective renal biopsy data was collected from 2009-2012 and patients with amyloidosis were identified and their clinical and biochemical parameters were analyzed. Results. Incidence of amyloidosis was 4.66% (n=24/514) among total renal biopsies. Among this, secondary amyloidosis constituted 87.5% of total amyloidosis. The commonest etiology in these patients was pulmonary tuberculosis (73.5%). All patients with tuberculosis had previously received DOTS treatment. 47.5% of patients with amyloidosis had renal impairment and 10.5% developed end-stage renal disease over 12 months and were dialysis dependent. Conclusions. Amyloidosis due to tuberculosis is a well-established, yet under-diagnosed complication of tuberculosis. The duration and treatment status of tuberculosis does not influence the occurrence of amyloidosis, as most of the patients were treated appropriately with DOTS. There are no predictive factors in patients who will develop secondary amyloidosis. At present there is no specific treatment apart from supportive therapy. The prognosis is poor, as most of these patients inexorably progress towards end-stage renal disease (ESRD) with significant mortality and morbidity. To conclude, at present we are only treating tuberculosis, we are yet to cure tuberculosis.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126820194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/bj-2014-0021
N. Prohić, H. Resić, G. Spasovski, F. Masnic, A. Bečiragić, Jelka Masin Spasovska, A. Ćorić
{"title":"Correlation of B-type Natriuretic Peptide (BNP) with Left Ventricle Systolic Function Echocardiographic Parameters in Patients with Chronic Kidney Disease (CKD)","authors":"N. Prohić, H. Resić, G. Spasovski, F. Masnic, A. Bečiragić, Jelka Masin Spasovska, A. Ćorić","doi":"10.2478/bj-2014-0021","DOIUrl":"https://doi.org/10.2478/bj-2014-0021","url":null,"abstract":"Abstract Introduction. BNP plasma levels are significantly increased in heart failure and have an excellent negative predictive value for left ventricular dysfunction. Measurement of BNP level is useful for “screening” in high-risk populations. It is suitable for detection of left ventricular hypertrophy (LVH) and/or dysfunction and risk assessment in the sub-acute phase of acute myocardial infarction in hypertensive patients. The aim of our study was to find whether BNP may correlate with the left ventricular systolic function, i.e. its echocardiographic parameters in chronic kidney disease (CKD) patients. Methods. In a prospective study performed at the Department of Nephrology and Clinic for hemodialysis at the Clinical Center in Sarajevo we followed-up 80 patients stratified in three separate groups according to CKD stage (Stage III, IV and V) for two years, regardless of their cardiovascular symptoms. We analyzed levels of BNP before and after diuretic therapy or hemodialysis and echocardiographic characteristics of the left ventricle. Results. There was a strong negative correlation between BNP values and the size of the EF before (rho=−0.692, p<0.0001) and after diuretic therapy (rho=−0.683, p<0.0001) for patients in CKD stage III, stage IV (rho=−0.314, p>0.05) and after diuretic therapy (rho=−495, p<0.05) Similarly, a negative correlation was found for BNP and EF values before (rho=−0.432, p<0.05) and after hemodialysis (rho=−0.556, p<0.01) for stage V CKD. Conclusions. Our study confirmed that the value of BNP in CKD patients may represent a measure of left ventricular systolic function with a strong negative correlation with ejection fraction. BNP measurement is a reliable parameter for further follow-up and prognosis in patients with established left ventricular dysfunction, acute coronary syndrome and for estimation of the left ventricular dysfunction.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121251728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/bj-2014-0023
Christos Paliouras, Foteini Lamprianou, Georgios Ntetskas, Georgios Mattas, N. Karvouniaris, G. Aperis, P. Alivanis
{"title":"Membranoproliferative Glomerulonephritis Type 1 Secondary to an Infected Ventriculoperitoneal Shunt: a Case Report","authors":"Christos Paliouras, Foteini Lamprianou, Georgios Ntetskas, Georgios Mattas, N. Karvouniaris, G. Aperis, P. Alivanis","doi":"10.2478/bj-2014-0023","DOIUrl":"https://doi.org/10.2478/bj-2014-0023","url":null,"abstract":"Abstract Ventricular shunting is the usual method for treatment of congenital or acquired hydrocephalus. Immune-mediated glomerulonephritis (shunt nephritis) is a rare but life-threatening complication of this neurosurgical technique. Intraglomerular deposition of circulating immune complexes and the subsequent activation of the classical pathway of serum complement’s cascade result in glomerular inflammation. Membranoproliferative gomerulonephritis is the most common histologic pattern observed in renal biopsy. The diagnosis needs high suspicion and is based on clinical and laboratory findings. Deterioration of renal function in association with signs of infection and low levels of serum complement’s proteins C3 and C4 make the diagnosis possible. The prognosis is variable and depends on the time of diagnosis after the onset of glomerular injury. The optimal treatment includes timely removal of the infected shunt in combination with aggressive antibiotic therapy. In this paper we present the case of a membranoproliferative glomerulonephritis type 1 in a patient with a ventriculoperitoneal shunt. Although this type of shunting is considered safer than the ventriculoatrial one, the risk of complications such as an immune-mediated glomerulonephritis still exists.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"107 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116006004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/bj-2014-0018
L. Orlić, I. Mikolasevic, Martina Pavletić-Peršić, I. Jelić, Sanja Raspor-Flajsman, S. Rački
{"title":"Kidney Complications Due to Hematopoietic Stem Cell Transplantation-A Disorder of an Increasing Incidence?","authors":"L. Orlić, I. Mikolasevic, Martina Pavletić-Peršić, I. Jelić, Sanja Raspor-Flajsman, S. Rački","doi":"10.2478/bj-2014-0018","DOIUrl":"https://doi.org/10.2478/bj-2014-0018","url":null,"abstract":"Abstract Hematopoietic stem cell transplantation (HSCT) is becoming an increasingly popular treatment considering that it is the only curative option for many malignant and non-malignant diseases. Many patients treated in this way have been followed for two or three decades post-transplant and are presumed to be cured. But, on the other hand, a great proportion of these patients are experiencing long-term side effects after HSCT, including non-malignant organ or tissue dysfunction, changes in quality of life, infections and secondary malignancy. Renal complications caused by HSCT are high and are associated with the development of both acute and chronic kidney failure. So, considering the increasing numbers of HSCT survivors many years after the transplantation, chronic kidney disease due to HSCT is becoming a growing problem and represents a new population of patients who are presented to nephrologists. The three most common forms of chronic kidney disease related to HSCT are: chronic calcineurin nephrotoxicity, glomerular disease after HSCT and HSCT associated thrombotic microangiopathy.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123424451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/BJ-2014-0015
G. Spasovski, M. Arıcı, D. Goumenos, N. Bašić-Jukić, N. Dimkovic, A. Schiller
{"title":"Another Reached Milestone with Bantao Journal - First Issue Associated Under De Gruyter Open Platform","authors":"G. Spasovski, M. Arıcı, D. Goumenos, N. Bašić-Jukić, N. Dimkovic, A. Schiller","doi":"10.2478/BJ-2014-0015","DOIUrl":"https://doi.org/10.2478/BJ-2014-0015","url":null,"abstract":"University Department of Nephrology, Medical Faculty, University \"Sts. Cyril and Methodius\", Skopje , R. Macedonia, Unit of Nephrology, Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey, Department of Nephrology and Renal Transplantation, University Hospital of Patras, Greece, School of Medicine University of Zagreb, University Hospital Centre Zagreb, Zagreb, Croatia, Clinical Department for Renal Diseases, Zvezdara University Medical Center, Belgrade, Serbia, Department of Nephrology, \"Victor Babes\" University of Medicine and Pharmacy, Timisoara, Romania","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128464529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/bj-2014-0017
Andreja Figurek, E. Papachristou, D. Goumenos
{"title":"Vascular Access for Hemodialysis: When and how?","authors":"Andreja Figurek, E. Papachristou, D. Goumenos","doi":"10.2478/bj-2014-0017","DOIUrl":"https://doi.org/10.2478/bj-2014-0017","url":null,"abstract":"Abstract As chronic kidney disease (CKD) progresses to the terminal stage, proper actions must be taken to prepare the patient for the initiation of the renal replacement therapy (RRT). If hemodialysis is an option for RRT, decisions should be made about the right vascular access for each individual patient. The available options for vascular access include the use of native arteriovenous fistulas (AVF), synthetic arteriovenous grafts (AVG) and double lumen dialysis catheters. With the help of ultrasound mapping, chances for choosing a right access are today very high. For hemodialysis patients the selection of the proper vascular access is of vital issue in regard of preventing complications and unnecessary procedures. Planning, creation and monitoring of the vascular access in dialysis patients should involve not only the nephrologist, but also the vascular surgeon and the interventional radiologist. Thus, multidisciplinary approach should be taken, in order to choose the way that has the most advantages and the least damage for the patient. That is the proper mode for hemodialysis patients to have longer and better quality of life.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"306 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122012430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/bj-2014-0016
E. Dounousi, A. Duni, K. Leivaditis, V. Liakopoulos
{"title":"Automated Peritoneal Dialysis: An alternative to Continuous Ambulatory or a First Choice Treatment?","authors":"E. Dounousi, A. Duni, K. Leivaditis, V. Liakopoulos","doi":"10.2478/bj-2014-0016","DOIUrl":"https://doi.org/10.2478/bj-2014-0016","url":null,"abstract":"Abstract The use of the various forms of Automated Peritoneal Dialysis (APD) has considerably increased in the past few years. This increase is driven by improved cycler design, apparent lifestyle advantages, and the increased ability to achieve adequacy and ultrafiltration targets. It is therefore reasonable to raise the question whether APD is superior to Continuous Ambulatory Peritoneal Dialysis (CAPD). APD is considered the most suitable Peritoneal Dialysis (PD) modality for high transporters as well as for assisted PD. It has also been associated with improved compliance, lower intraperitoneal pressure and possibly lower incidence of peritonitis. On the other hand, there are concerns regarding increased cost, a more rapid decline in residual renal function, inadequate sodium removal and disturbed sleep. Besides its beneficial results in high transporters, other medical advantages of APD still remain unclear. Individual patient’s choice remains the most important indication for applying APD, which should be made available to all patients starting PD.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130992048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 2014-12-01DOI: 10.2478/bj-2014-0019
Ana Belazelkovska, M. Popovska, G. Spasovski, J. Masin‐Spasovska, S. Cekovska, A. Atanasovska-Stojanovska, K. Mitic, V. Radojkova-Nikolovska
{"title":"Oral and Salivary Changes in Patients with Chronic Kidney Disease","authors":"Ana Belazelkovska, M. Popovska, G. Spasovski, J. Masin‐Spasovska, S. Cekovska, A. Atanasovska-Stojanovska, K. Mitic, V. Radojkova-Nikolovska","doi":"10.2478/bj-2014-0019","DOIUrl":"https://doi.org/10.2478/bj-2014-0019","url":null,"abstract":"Abstract Introduction. Kidney disease is associated with many abnormalities in the oral health status as well as with alterations in salivary flow and composition. The aim of this study was to evaluate and to correlate oral clinical findings, salivary flow (SF) and salivary pH values in patients with chronic kidney disease (CKD) not yet on hemodyalisis treatment, those undergoing hemodialysis and in kidney transplant recipients. Methods. In a cross-sectional study 90 patients were included. The cohort was composed of three groups: 30 patients with CKD (serum creatinine values under 120 μmol/L-group 1), 30 patients with CKD on hemodialysis (group 2) and 30 kidney transplanted patients (group 3). The control group consisted of 20 healthy individuals. Oral symptoms, signs and lesions: salivary volume, salivary pH and SF of stimulated and unstimulated saliva were evaluated. Results. Among patients with CKD without dialysis treatment inverse relationship was found between uremic fetor, unpleasant taste and unstimulated SF and also between xerostomia and stimulated SF. Negative correlation between thirst and unstimulated salivary flow was found in both groups, patients with CKD on dialysis and kidney transplant group. Furthermore, in kidney-transplant patients a negative correlation was found between petechiae and SF, while in group of patients with CKD on hemodialysis the same negative correlation was registered between uremic fetor and stimulated SF. Conclusions. Salivary flow was significantly lower in hemodialysis patients, while the highest was in the kidney-transplant recipients accompanied with improvement in the other oral clinical findings observed in our study.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133957969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 1900-01-01DOI: 10.1515/bj-2015-0002
Aleksandar N. Janković, J. Ikonomovski, P. Djuric, M. Mitrović, J. Tosic Dragovic, A. Bulatović, Jasmina Lipkovski-Markovic, G. Basta-Jovanovic, D. Vujić, N. Dimkovic
{"title":"Epidemiological Review of Kidney Biopsy during 30 years - Single Center Experience","authors":"Aleksandar N. Janković, J. Ikonomovski, P. Djuric, M. Mitrović, J. Tosic Dragovic, A. Bulatović, Jasmina Lipkovski-Markovic, G. Basta-Jovanovic, D. Vujić, N. Dimkovic","doi":"10.1515/bj-2015-0002","DOIUrl":"https://doi.org/10.1515/bj-2015-0002","url":null,"abstract":"Abstract Introduction. Renal biopsy represents a diagnostic method that provides an acurrate diagnosis and adequate treatment of different renal diseases. The first biopsy in our Center was done in June 1982, but it has been performing routinely since 1984. The aim of this study was to report the histopathological features of biopsy proven kidney disease during the past 30 years. Methods. During 30 years, a total of 563 biopsies were performed, of which 530(94%) were succesfull. Data about gender, age, clinical syndrome and histopatological finding were collected from the medical records. Results. The mean age of our patients was 48±11 years, 53% were man (No=272). In the first decade (1982-1994) we performed 118(mean age 50±13), in the second (1995- 2004) 208 (mean age 46±14), and in the third decade (2005-2014) 189 renal biopsies (mean age 50±16). Mean number of glomeruli per biopsy was 18±11. There were only two serious complications. The most common clinical syndromes as indication for renal biopsy were: nephrotic proteinuria (41%) followed by asymptomatic urinary abnormalities (AUA-14.8%), chronic renal failure (CRF-13.8%), acute kidney injury (AKI-12.8%), nephritic syndrome (7.6%), systemic lupus erytematosus (SLE- 4.5%), isolated haematuria (2.7% of the cases) and other (2.9%). The major histological groups identified were: primary glomerulonephritis (GN) (62.3%), secondary GN (21.2%), and other (16.5% of the cases). The most common primary glomerulonephritis (PGN) were focal segmental glomerulosclerosis-FSGS (19.4%) followed by IgA nephropathy-IgAN (18.8%), membranous GNMGN (16.4%) and mesangial proliferation-MesGN (16%). Interstitial changes were present in 55% of biopsy samples in the first, in 66% in the second and in 63% in the third decade. Blood vessel changes were present in 39% of biopsy samples in the first, in 62% in the second and in 72% in the third decade. Conclusions. The most frequent finding among PGN was mesangioproliferative GN (including IgAN, alltogether 34.8%) followed by FSGS and MGN. Apart from succesful biopsies, there are several aspects to be improved in the future including expanding indications and earlier procedure during the course of chronic kidney disease-CKD.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114147485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BANTAO JournalPub Date : 1900-01-01DOI: 10.2478/bj-2014-0001
G. Spasovski, P. Cochat, F. Claas, U. Heemann, J. Pascual, C. Dudley, P. Harden, M. Hourmant, U. Maggiore, M. Salvadori, J. Squifflet, J. Steiger, Armando Torres, O. Viklicky, M. Zeier, R. Vanholder, W. Biesen, E. Nagler, D. Abramowicz
{"title":"European Renal Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care","authors":"G. Spasovski, P. Cochat, F. Claas, U. Heemann, J. Pascual, C. Dudley, P. Harden, M. Hourmant, U. Maggiore, M. Salvadori, J. Squifflet, J. Steiger, Armando Torres, O. Viklicky, M. Zeier, R. Vanholder, W. Biesen, E. Nagler, D. Abramowicz","doi":"10.2478/bj-2014-0001","DOIUrl":"https://doi.org/10.2478/bj-2014-0001","url":null,"abstract":"Abstract The Clinical Practice Guideline on evaluation of the kidney donor and transplant recipient was developed following a rigorous methodological approach aiming to provide information and aid decision-making to the transplant professionals. Thus, this document should help caregivers to improve the quality of care they deliver to patients with no intention it is defined as a standard of care. In this short version of the guidelines we present 112 statements about the evaluation of the kidney transplant candidate as well as the potential deceased and living donor, the immunological work-up of kidney donors and recipients and the perioperative recipient care. The extended version of the guidelines with methods, rationale and references is published in Nephrol Dial Transplant (2013) 28: i1-i71; doi: 10.1093/ndt/gft218 and can be downloaded freely from http://www.oxfordjournals.org/our_journals/ndt/era_edta.html.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115938501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}